Search for: "Sanofi GmbH" Results 21 - 40 of 72
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jul 2013, 3:51 am
It granted a licence to Sanofi-Aventis Deutschland GmbH to distribute it in Greece, under an authorisation to place it on the market granted by the competent Greek authorities in 1999. [read post]
13 Dec 2013, 10:59 am
Among those being sued in the US are Grunenthal GMBH and American companies Merrell Richardson, now Sanofi-Aventis, and Smith, Kline and French, now GlaxoSmithKline. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 8/21: Aventis Pharama S.A., Sanofi-Aventis US LLC v. [read post]
16 Dec 2008, 11:47 pm
  In contrast, in Aventis Pharma Deutschland GmbH v. [read post]
19 Jun 2011, 9:00 pm by Laurent
Le recours aurait donc dû être formé au nom de Sanofi-Aventis Deutschland GmbH. [read post]
12 Oct 2011, 3:46 am by Marie Louise
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog)   Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification (Patent Docs) Exelon (Rivastigmine)… [read post]
19 Jun 2011, 3:01 pm by Oliver G. Randl
., adversely affected – see A 107) by the decision was Nutrinova (the food ingredients business of Celanese Ventures GmbH, to which company the relevant business assets had been transferred in July 2002). [read post]
11 Nov 2022, 9:40 am by Holman
Sanofi, marking the first time that the Court has taken up patent law’s enablement requirement since enactment of the Patent Act of 1952. [read post]
5 May 2010, 4:46 am
(Patent Docs) Plavix (Clopidogrel) – Netherlands: District Court of The Hague finds Sanofi-Aventis’ patent invalid for lack of inventive step in proceedings brought by RatioPharm (EPLAW) Rapamune (Sirolimus) – US: Patent infringement complaint following Paragraph IV certification: Pfizer Inc. et al. v. [read post]
10 Oct 2011, 7:33 am
It's Case C-414/11 Daiichi Sankyo Company Limited, Sanofi-Aventis Deutschland GmbH v DEMO Anonimos Viomikhaniki kai Emporiki Etairia Farmakon and it comes all the way from the Polimeles Protodikio Athinon (Greece). [read post]
15 Oct 2010, 7:49 am by Keith Lee
It’s just how Sanofi-aventis, Proctor and Gamble and Citibank stay competitive!! [read post]